News
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Evotec SE announces strong progress in strategic partnership with Bristol Myers Squibb for molecular glue degraders, triggering payments of US$75m. Joint pipeline expanding in oncology field -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec SE reports first half-year 2024 results on 14 August 2024
Evotec SE to report first half-year 2024 results on 14 August 2024. Conference call scheduled to discuss financial performance and updates. Webcast available on www.evotec.com/en/investor-relations/financial-publications -